The U.S. Food and Drug Administration (FDA) authorized Johnson & Johnson’s COVID-19 vaccine for emergency use on Saturday (Feb. 27), making it the third shot cleared for use in the country. Source: https://www.livescience.com/johnson-and-johnson-covid-19-vaccine-emergency-use.html
Tag: Johnson & Johnson
America Authorizes Johnson & Johnson’s COVID-19 Vaccine For Emergency Use
America’s Food and Drug Administration just authorized Johnson & Johnson’s COVID-19 vaccine for emergency use, according to CBS News. “The vaccine is the third to be approved for use in the United States, and the first that requires only one shot…” Among people who got the vaccine in clinical trials, there were no COVID-related deaths. Phase 3 clinical trials also showed…
Who should get the Johnson & Johnson vaccine over the mRNA vaccines?
Each vaccine has its pros and cons, but all work extremely well. Source: https://www.livescience.com/which-covid-19-vaccine-should-you-get.html
COVID-19 vaccines: What does 95% efficacy actually mean?
You have likely heard that Pfizer’s COVID-19 vaccine efficacy is 95%, Moderna’s is 94% and Johnson & Johnson’s is 66%. But what do these numbers actually mean? Source: https://www.livescience.com/covid-19-vaccine-efficacy-explained.html
Some Coronavirus Vaccine Trials Resort To Pen and Paper After Ransomware Hits Software
A software company supporting hundreds of clinical trials — including coronavirus vaccine trials — has been hit by a ransomware attack that “has slowed some of those trials over the past two weeks,” reports the New York Times. Employees “discovered that they were locked out of their data by ransomware…” eResearchTechnology (ERT) said clinical trial patients were never at risk, but…
Johnson & Johnson’s Covid-19 Vaccine Produces Strong Immune Response in Early Trial
Newsweek reports:
Pharmaceutical manufacturer Johnson & Johnson announced Friday that early trials of a COVID-19 vaccine showed a 98 percent success rate in showing a boost in the immune system. According to research from Johnson & Johnson, the vaccine enabled 98 percent of those who took it to create antibodies that fight off the coronavirus infection. Those neutralizing antibodies were present 29…
US Reaches $1 Billion Deal For Doses of Potential Johnson & Johnson Vaccine
An anonymous reader quotes a report from The Hill: The Trump administration on Wednesday announced a deal worth approximately $1 billion for the manufacturing of 100 million doses of a potential coronavirus vaccine from Johnson & Johnson that the federal government would then own. The move is the latest in a series of agreements the Trump administration has made with several…
Pre-Clinical Test of Johnson & Johnson Vaccine Shows It Protected Monkeys from Covid-19
“Johnson & Johnson’s experimental coronavirus vaccine protected macaque monkeys with a single shot in a pre-clinical study, potentially gaining on other vaccines that are further along in testing but require two doses over time,” reports Bloomberg:
Five of six primates exposed to the pandemic-causing pathogen were immune after a single injection. The exception showed low levels of the virus, according to a…
Several Pharmaceutical Companies Are Racing To Develop a Coronavirus Vaccine
“The race for a vaccine to combat the new coronavirus is moving faster than researchers and drugmakers expected,” reported Dow Jones News Services this week, “with Pfizer Inc. joining several other groups saying that they had accelerated the timetable for testing and that a vaccine could be ready for emergency use in the fall.”
Pfizer said Tuesday it will begin testing of…
FDA Approves First-Ever Ebola Vaccine
An anonymous reader quotes a report from ABC News: The U.S. Food and Drug Administration has for the first time approved a vaccine for the prevention of the deadly Ebola virus disease. The agency announced the approval of Ervebo, a single-dose, injectable vaccine manufactured by American pharmaceutical company Merck. The announcement, made Thursday, comes a month after the European Union and…